Adaptive Biotechnologies
ADPT
$7.71
Share price
-0.90%
Change (1 day)
-78.65%
Change (1 year)
Categories
Market capitalization of Adaptive Biotechnologies (ADPT)
Market cap: $1.09 Billion
As of May 2022 Adaptive Biotechnologies has a market cap of $1.09 Billion. This makes Adaptive Biotechnologies the world's 4234th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Adaptive Biotechnologies from 2019 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $1.09 B | -72.31% |
| 2021 | $3.96 B | -51.03% |
| 2020 | $8.08 B | 115.83% |
| 2019 | $3.74 B |
End of Day market cap according to different sources
On May 21st, 2022 the market cap of Adaptive Biotechnologies was reported to be:
$1.09 Billion
$1.09 Billion
$1.09 Billion
$1.08 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 HCA Healthcare HCA | $60.50 B | 5,418.00% | 🇺🇸 USA |
 Premier PINC | $4.38 B | 299.83% | 🇺🇸 USA |
 Community Health Systems
CYH | $0.78 B | -28.76% | 🇺🇸 USA |
 Select Medical Holdings SEM | $3.17 B | 189.47% | 🇺🇸 USA |